Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $24.71 USD
Change Today +0.74 / 3.09%
Volume 144.1K
FLXN On Other Exchanges
As of 8:10 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael D. Clayman M.D.

Co-Founder, Chief Executive Officer, President and Director,Flexion Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 19 board members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Michael D. Clayman, also known as Mike, MD, co-founded Flexion Therapeutics, Inc. (formerly, Flexion Development Partners, Inc) in 2007 and has been its Chief Executive Officer and President since 2007. Dr. Clayman has over 20 years of experience in pharmaceutical development. He served as Vice President at Lilly Research Laboratories at at Eli Lilly and Company and its General Manager of Chorus, Lilly's development accelerator. During a long career at Lilly, Dr. ...

Read Full Background

Corporate Headquarters*

10 Mall Road
Burlington, Massachusetts 01803

United States

Phone: 781-305-7777
Fax: 781-202-3399

Board Members Memberships*

Co-Founder, Chief Executive Officer, President and Director
Director and Member of Nominating & Corporate Governance Committee


Yale University
University of California San Diego School of Medicine

Other Affiliations*

Annual Compensation*

Total Annual Compensation$675,306

Stock Options*

All Other Compensation$32,357
Exercisable Options95,011
Unexercisable Options256,888
Total Number of Options351,899

Total Compensation*

Total Annual Cash Compensation$707,663
Total Short Term Compensation$675,306
Other Long Term Compensation$32,357
Total Calculated Compensation$2,857,381
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FLXN:US $24.71 USD +0.74


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FLEXION THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at